Refractory Severe Esophagitis During Durvalumab Therapy in a Patient With Locally Advanced NSCLC

Takahiro Utsumi, Kazuya Tsubouchi, Taishi Harada

研究成果: ジャーナルへの寄稿 › レター › 査読

本文言語	英語
ページ（範囲）	e40-e42
ジャーナル	Journal of Thoracic Oncology
巻	14
号	2
DOI	https://doi.org/10.1016/j.jtho.2018.10.153
出版ステータス	出版済み - 2月 2019
外部発表	はい

!!!All Science Journal Classification (ASJC) codes

@article{6f88d5e55842451dad04f875a925154f,

title = "Refractory Severe Esophagitis During Durvalumab Therapy in a Patient With Locally Advanced NSCLC",

author = "Takahiro Utsumi and Kazuya Tsubouchi and Taishi Harada",

year = "2019",

month = feb,

doi = "10.1016/j.jtho.2018.10.153",

language = "English",

volume = "14",

pages = "e40--e42",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "International Association for the Study of Lung Cancer",

number = "2",

}

TY - JOUR

T1 - Refractory Severe Esophagitis During Durvalumab Therapy in a Patient With Locally Advanced NSCLC

AU - Utsumi, Takahiro

AU - Tsubouchi, Kazuya

AU - Harada, Taishi

PY - 2019/2

Y1 - 2019/2

UR - http://www.scopus.com/inward/record.url?scp=85060289154&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060289154&partnerID=8YFLogxK

U2 - 10.1016/j.jtho.2018.10.153

DO - 10.1016/j.jtho.2018.10.153

M3 - Letter

C2 - 30683299

AN - SCOPUS:85060289154

SN - 1556-0864

VL - 14

SP - e40-e42

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 2

ER -